The University of Cambridge Metabolic Research Laboratories and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the MRL.
Latest News
Obesity associated with genetic conditions that affect wiring of brain centres controlling weight
In a recent paper published in Cell, Dr Agatha van der Klaauw and colleagues in Professor Sadaf Farooqi’s team describe…
Identifying GDF15 as an endocrine signal of nutritional stress
Work led by Stephen O’Rahilly, David Savage and Tony Coll from the Institute of Metabolic Science and MRC Metabolic Diseases Unit…
Cambridge ranked as top type 1 diabetes research institution in the UK
A list of the most influential UK researchers in type 1 diabetes in terms of impact has been published, as…
Giles Yeo to present JBS Haldane Lecture in centenary year
The Genetics Society has announced Dr Giles Yeo as winner of their centenary year JBS Haldane Lecture. Giles will present his…
